drugset / Trial / NCT02331706
IFN-DLI for Relapsed Acute Leukemia After Allo-SCT
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is designed to determine the feasibility of conventional induction chemotherapy, IFNand G-CSF mobilized DLI (IFN-DLI) in subjects with relapsed AML and ALL after allo-SCT.
Timeline
- Start
- 2014-12
- Primary completion
- 2016-11-11
- Completion
- 2017-11-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | interferon alfa-2b | Protein / enzyme biologic | 3e+06 iu | Subcutaneous |